Whilst we cannot currently comment on the potential immunogenicity of this MALAT1 derived peptide, other studies where bioinformatics approaches have been deployed suggested that tumour associated antigens can be derived from non-canonical parts of the genome although, to our knowledge, this concept remains to be proven34–38. This evidence concerns the gene MALAT1 and neoplasm.